More than twice as many men than women die from skin cancer - 1297 compared with 600 women in 2010-2011 (from total incidences of 260,148 and 185,010). Young men are especially likely to think that their risk of skin cancer is low - 62 per cent compared with 50 per cent of women.
Read more by clicking on the following link:
Hunter role in global melanoma research
Hunter Medical Research Institute Professor Xu Dong Zhang and University of Newcastle molecular biologist Dr Rick Thorne are among 21 scientists from 10 institutes in Australia and China who have discovered the role of a molecule responsible for a chain reaction that leads to melanoma.
For the full article, click this link. http://www.theherald.com.au/story/1328960/hunter-role-in-global-melanoma-research/
Combining MEK, BRAF inhibitors in Melanoma
Vienna, Austria—Mounting evidence shows that combining a MEK inhibitor and a BRAF inhibitor could be the future standard of care for metastatic melanoma. The dual-blockade strategy was supported by two studies that tested two different combinations, both reported at the annual meeting of the European Society for Medical Oncology (ESMO).
For the full article, click this link. http://www.clinicaloncology.com/ViewArticle.aspx?d=Solid%2BTumors&d_id=148&i=February+2013&i_id=932&a_id=22579